Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study

Ashish Sharma, Ahmed Abdelshafy Tabl, Heba T. Rihani, Marwa Abdelshafy Tabl, Ahmed A. Shebl, Walid Samir Abousaif, Mutasem Elfalah, Moayad Shaf”ei, Tabarak AlSaadi, Unknown, Arshad M. Khanani, David Eichenbaum, Carl Regillo, David Boyer, Baruch D. Kuppermann, Anat Loewenstein, Francesco Bandello, Giuseppe Querques, Tomoko Ueda-Consolvo, Masaaki Ishida, Tomoko Nakamura, Atsushi Hayashi, Kotaro Tsuboi, Nilesh Kumar, Nikulaa Parachuri, Jay Sheth, Chitaranjan Mishra, Debdulal Chakraborty, Alay Banker, Kourous A. Rezaei, Peter K. Kaiser, Frank G. Holz, Sobha Sivaprasad, Şengül Özdek, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Valentina Sarao, Caroline Baumal, Nancy Holekemp, Taiji Sakamoto, Adnan Tufail, Nicolas Yannuzzi, Giulia Corradetti, Aleksandra Rachitskaya, Tunde Peto, Maximilian WM Wintergerst, Barbara Parolini, Quan Dong Nguyen, V. D. Diana, Pearse A. Keane, Tarek Hassan, Dilraj S. Grewal, Francesc March, Martin S. Spitzer, Khalil G. Falavarjani, Martin S. Zinkernagel, Christopher Seungkyu Lee, Judy E. Kim, Se Joon Woo, Luke Nicholson, Clara Vazquez-Alfageme, Taku Wakabayashi

Open source

DOI: 10.1038/s41433-026-04537-7
Published: 2026-05-16
Container: Eye
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41433-026-04537-7,
title = {Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study},
author = {Ashish Sharma and Ahmed Abdelshafy Tabl and Heba T. Rihani and Marwa Abdelshafy Tabl and Ahmed A. Shebl and Walid Samir Abousaif and Mutasem Elfalah and Moayad Shaf”ei and Tabarak AlSaadi and Unknown and Arshad M. Khanani and David Eichenbaum and Carl Regillo and David Boyer and Baruch D. Kuppermann and Anat Loewenstein and Francesco Bandello and Giuseppe Querques and Tomoko Ueda-Consolvo and Masaaki Ishida and Tomoko Nakamura and Atsushi Hayashi and Kotaro Tsuboi and Nilesh Kumar and Nikulaa Parachuri and Jay Sheth and Chitaranjan Mishra and Debdulal Chakraborty and Alay Banker and Kourous A. Rezaei and Peter K. Kaiser and Frank G. Holz and Sobha Sivaprasad and Şengül Özdek and Kodjikian Laurent and Alper Bilgic and Paolo Lanzetta and Valentina Sarao and Caroline Baumal and Nancy Holekemp and Taiji Sakamoto and Adnan Tufail and Nicolas Yannuzzi and Giulia Corradetti and Aleksandra Rachitskaya and Tunde Peto and Maximilian WM Wintergerst and Barbara Parolini and Quan Dong Nguyen and V. D. Diana and Pearse A. Keane and Tarek Hassan and Dilraj S. Grewal and Francesc March and Martin S. Spitzer and Khalil G. Falavarjani and Martin S. Zinkernagel and Christopher Seungkyu Lee and Judy E. Kim and Se Joon Woo and Luke Nicholson and Clara Vazquez-Alfageme and Taku Wakabayashi},
year = {2026},
journal = {Eye},
doi = {10.1038/s41433-026-04537-7},
url = {https://doi.org/10.1038/s41433-026-04537-7}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study
AU  - Ashish Sharma
AU  - Ahmed Abdelshafy Tabl
AU  - Heba T. Rihani
AU  - Marwa Abdelshafy Tabl
AU  - Ahmed A. Shebl
AU  - Walid Samir Abousaif
AU  - Mutasem Elfalah
AU  - Moayad Shaf”ei
AU  - Tabarak AlSaadi
AU  - Unknown
AU  - Arshad M. Khanani
AU  - David Eichenbaum
AU  - Carl Regillo
AU  - David Boyer
AU  - Baruch D. Kuppermann
AU  - Anat Loewenstein
AU  - Francesco Bandello
AU  - Giuseppe Querques
AU  - Tomoko Ueda-Consolvo
AU  - Masaaki Ishida
AU  - Tomoko Nakamura
AU  - Atsushi Hayashi
AU  - Kotaro Tsuboi
AU  - Nilesh Kumar
AU  - Nikulaa Parachuri
AU  - Jay Sheth
AU  - Chitaranjan Mishra
AU  - Debdulal Chakraborty
AU  - Alay Banker
AU  - Kourous A. Rezaei
AU  - Peter K. Kaiser
AU  - Frank G. Holz
AU  - Sobha Sivaprasad
AU  - Şengül Özdek
AU  - Kodjikian Laurent
AU  - Alper Bilgic
AU  - Paolo Lanzetta
AU  - Valentina Sarao
AU  - Caroline Baumal
AU  - Nancy Holekemp
AU  - Taiji Sakamoto
AU  - Adnan Tufail
AU  - Nicolas Yannuzzi
AU  - Giulia Corradetti
AU  - Aleksandra Rachitskaya
AU  - Tunde Peto
AU  - Maximilian WM Wintergerst
AU  - Barbara Parolini
AU  - Quan Dong Nguyen
AU  - V. D. Diana
AU  - Pearse A. Keane
AU  - Tarek Hassan
AU  - Dilraj S. Grewal
AU  - Francesc March
AU  - Martin S. Spitzer
AU  - Khalil G. Falavarjani
AU  - Martin S. Zinkernagel
AU  - Christopher Seungkyu Lee
AU  - Judy E. Kim
AU  - Se Joon Woo
AU  - Luke Nicholson
AU  - Clara Vazquez-Alfageme
AU  - Taku Wakabayashi
PY  - 2026
JO  - Eye
DO  - 10.1038/s41433-026-04537-7
UR  - https://doi.org/10.1038/s41433-026-04537-7
ER  -

APA

Sharma, A., Tabl, A. A., Rihani, H. T., Tabl, M. A., Shebl, A. A., Abousaif, W. S., Elfalah, M., Shaf”ei, M., AlSaadi, T., Unknown, Khanani, A. M., Eichenbaum, D., Regillo, C., Boyer, D., Kuppermann, B. D., Loewenstein, A., Bandello, F., Querques, G., Ueda-Consolvo, T., Ishida, M., Nakamura, T., Hayashi, A., Tsuboi, K., Kumar, N., Parachuri, N., Sheth, J., Mishra, C., Chakraborty, D., Banker, A., Rezaei, K. A., Kaiser, P. K., Holz, F. G., Sivaprasad, S., Özdek, Ş., Laurent, K., Bilgic, A., Lanzetta, P., Sarao, V., Baumal, C., Holekemp, N., Sakamoto, T., Tufail, A., Yannuzzi, N., Corradetti, G., Rachitskaya, A., Peto, T., Wintergerst, M. W., Parolini, B., Nguyen, Q. D., Diana, V. D., Keane, P. A., Hassan, T., Grewal, D. S., March, F., Spitzer, M. S., Falavarjani, K. G., Zinkernagel, M. S., Lee, C. S., Kim, J. E., Woo, S. J., Nicholson, L., Vazquez-Alfageme, C., & Wakabayashi, T. (2026). Real-world effectiveness and safety of ranibizumab biosimilar FYB-201 in Saudi Arabia (Ravegza) and Jordan (Uptera): a middle eastern extension of the FORCE study. Eye. https://doi.org/10.1038/s41433-026-04537-7

Source records

crossref · retrieved 2026-09-26T01:46:31.102Z